Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 4
1989 3
1991 3
1992 2
1993 1
1995 2
1997 5
1998 3
1999 5
2000 3
2001 6
2002 3
2003 9
2004 1
2005 10
2006 10
2007 17
2008 13
2009 27
2010 22
2011 13
2012 19
2013 23
2014 27
2015 34
2016 44
2017 46
2018 51
2019 65
2020 62
2021 62
2022 55
2023 56
2024 39

Text availability

Article attribute

Article type

Publication date

Search Results

632 results

Results by year

Filters applied: . Clear all
Page 1
Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia.
Wakita S, Sakaguchi M, Oh I, Kako S, Toya T, Najima Y, Doki N, Kanda J, Kuroda J, Mori S, Satake A, Usuki K, Ueki T, Uoshima N, Kobayashi Y, Kawata E, Tajika K, Nagao Y, Shono K, Shibusawa M, Tadokoro J, Kayamori K, Hagihara M, Uchiyama H, Uchida N, Kubota Y, Kimura S, Nagoshi H, Ichinohe T, Kurosawa S, Motomura S, Hashimoto A, Muto H, Sato E, Ogata M, Mitsuhashi K, Ando J, Marumo A, Omori I, Fujiwara Y, Terada K, Yui S, Arai K, Kitano T, Miyata M, Kurosawa A, Mizoguchi A, Komatsu N, Fukuda T, Ohashi K, Kanda Y, Inokuchi K, Yamaguchi H. Wakita S, et al. Among authors: ichinohe t. Blood Adv. 2022 Jan 11;6(1):238-247. doi: 10.1182/bloodadvances.2021004292. Blood Adv. 2022. PMID: 34448807 Free PMC article.
A pharmacogenetics approach to pain management.
Yoshida K, Nishizawa D, Ide S, Ichinohe T, Fukuda KI, Ikeda K. Yoshida K, et al. Among authors: ichinohe t. Neuropsychopharmacol Rep. 2018 Mar;38(1):2-8. doi: 10.1002/npr2.12003. Epub 2018 Feb 6. Neuropsychopharmacol Rep. 2018. PMID: 30106264 Free PMC article. Review.
T cell receptor-engineered T cells derived from target human leukocyte antigen-DPB1-specific T cell can be a potential tool for therapy against leukemia relapse following allogeneic hematopoietic cell transplantation.
Katsuyama N, Kawase T, Barakat C, Mizuno S, Tomita A, Ozeki K, Nishio N, Sato Y, Kajiya R, Shiraishi K, Takahashi Y, Ichinohe T, Nishikawa H, Akatsuka Y. Katsuyama N, et al. Among authors: ichinohe t. Nagoya J Med Sci. 2023 Nov;85(4):779-796. doi: 10.18999/nagjms.85.4.779. Nagoya J Med Sci. 2023. PMID: 38155626 Free PMC article.
Response of host inflammasomes to viral infection.
Chen IY, Ichinohe T. Chen IY, et al. Among authors: ichinohe t. Trends Microbiol. 2015 Jan;23(1):55-63. doi: 10.1016/j.tim.2014.09.007. Epub 2014 Oct 22. Trends Microbiol. 2015. PMID: 25456015 Review.
Clinical Implications of t(11;14) in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation.
Takamatsu H, Yamashita T, Kurahashi S, Saitoh T, Kondo T, Maeda T, Nakazawa H, Murata M, Narita T, Kuroda J, Hashimoto H, Kawamura K, Miyamoto T, Honda S, Ichinohe T, Atsuta Y, Sunami K. Takamatsu H, et al. Among authors: ichinohe t. Biol Blood Marrow Transplant. 2019 Mar;25(3):474-479. doi: 10.1016/j.bbmt.2018.11.003. Epub 2018 Nov 10. Biol Blood Marrow Transplant. 2019. PMID: 30423479 Free article.
Antibody-mediated pathogenesis of chronic GVHD through DBY/HLA class II complexes and induction of a GVL effect.
Umino K, Morita K, Ikeda T, Kawaguchi SI, Nagayama T, Ito S, Minakata D, Ashizawa M, Yamamoto C, Hatano K, Sato K, Ohmine K, Fujiwara SI, Kimura SI, Kako S, Doki N, Ozawa Y, Mori Y, Eto T, Hiramoto N, Nakamae H, Kanda J, Ichinohe T, Atsuta Y, Nakasone H, Morishima S, Kanda Y. Umino K, et al. Among authors: ichinohe t. Blood. 2023 Sep 14;142(11):1008-1021. doi: 10.1182/blood.2023019799. Blood. 2023. PMID: 37363859 Free article.
632 results